— Know what they know.
Not Investment Advice
Also trades as: PLX.TA (TLV) · $vol 0M

PLX AMEX

Protalix BioTherapeutics, Inc.
1W: +1.5% 1M: -7.7% 3M: -33.7% YTD: +16.7% 1Y: +18.0% 3Y: -6.5% 5Y: -25.9%
$2.10
+0.07 (+3.45%)
 
Weekly Expected Move ±5.6%
$2 $2 $2 $2 $2
AMEX · Healthcare · Biotechnology · Alpha Radar Sell · Power 46 · $169.2M mcap · 72M float · 1.32% daily turnover · Short 43% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
52.5 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 37.6%
Cost Advantage ★
63
Intangibles
51
Switching Cost
57
Network Effect
59
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. PLX shows a Weak competitive edge (52.5/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 37.6% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 5Hold: 2Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$—
Analysts0

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A-
May 22, 2026
DCF
1
ROE
5
ROA
5
D/E
3
P/E
3
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. PLX receives an overall rating of A-. Strongest factors: ROE (5/5), ROA (5/5). Areas of concern: DCF (1/5).
Rating Change History
DateFromTo
2026-05-13 C- A-
2026-03-18 B- C-
2026-03-16 B B-
2026-01-20 B- B
2026-01-16 B B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

66 Grade A+
Profitability
100
Balance Sheet
93
Earnings Quality
80
Growth
79
Value
62
Momentum
91
Safety
0
Cash Flow
71
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. PLX scores highest in Profitability (100/100) and lowest in Safety (0/100). An overall grade of A+ places PLX among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-1.05
Distress Zone
Piotroski F-Score
7/9
Beneish M-Score
-0.80
Possible Manipulator
Ohlson O-Score
-8.47
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BBB+
Score: 63.6/100
Trend: Improving
Earnings Quality
75/100
OCF/NI: 0.98x
Accruals: 0.3%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. PLX scores -1.05, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. PLX scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. PLX's score of -0.80 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. PLX's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. PLX receives an estimated rating of BBB+ (score: 63.6/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). PLX's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
10.94x
PEG
-0.01x
P/S
2.22x
P/B
2.49x
P/FCF
12.31x
P/OCF
11.94x
EV/EBITDA
7.95x
EV/Revenue
2.28x
EV/EBIT
8.54x
EV/FCF
11.88x
Earnings Yield
8.51%
FCF Yield
8.12%
Shareholder Yield
0.00%
Graham Number
$1.55
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 10.9x earnings, PLX trades at a reasonable valuation. An earnings yield of 8.5% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $1.55 per share, 35% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.796
NI / EBT
×
Interest Burden
0.947
EBT / EBIT
×
EBIT Margin
0.266
EBIT / Rev
×
Asset Turnover
0.981
Rev / Assets
×
Equity Multiplier
1.703
Assets / Equity
=
ROE
33.5%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. PLX's ROE of 33.5% is driven by Asset Turnover (0.981), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
261.92%
Fair P/E
532.33x
Intrinsic Value
$98.28
Price/Value
0.02x
Margin of Safety
97.79%
Premium
-97.79%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with PLX's realized 261.9% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $98.28, PLX appears undervalued with a 98% margin of safety. The adjusted fair P/E of 532.3x compares to the current market P/E of 10.9x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$2.10
Median 1Y
$1.39
5th Pctile
$0.37
95th Pctile
$5.21
Ann. Volatility
79.0%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Dror Bashan
President and Chief Executive Officer
$401,836 $190,015 $1,166,934
Eyal Rubin Financial
ce President and Chief Financial Officer
$240,576 $183,393 $832,461
Yaron Naos President,
e President, Chief Operating Officer
$232,784 $77,804 $575,769
Gilad Mamlok Financial
ce President and Chief Financial Officer
$133,919 $— $405,225

CEO Pay Ratio

23:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $1,166,934
Avg Employee Cost (SGA/emp): $51,690
Employees: 226

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
226
+6.1% YoY
Revenue / Employee
$233,381
Rev: $52,744,000
Profit / Employee
$-29,221
NI: $-6,604,000
SGA / Employee
$51,690
Avg labor cost proxy
R&D / Employee
$86,588
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 42.6% 42.1% 1.7% 1.5% 1.1% 1.1% 1.8% 1.9% -1.1% -1.3% 72.5% 59.7% -1.3% -83.8% 7.6% 10.2% 16.3% 14.1% -14.4% 33.5% 33.53%
ROA -36.6% -36.2% -39.0% -34.5% -26.1% -25.2% -23.1% -24.4% 13.8% 16.4% 11.9% 9.8% -21.0% -13.7% 3.7% 5.0% 8.0% 6.8% -8.5% 19.7% 19.69%
ROIC 8.4% 8.0% 1.4% 1.3% 1.0% 1.1% -15.7% -16.4% 16.9% 18.7% 60.8% 48.8% -69.9% -42.1% 19.9% 25.2% 45.9% 38.1% -10.4% 37.6% 37.62%
ROCE 64.2% 60.6% -49.0% -45.0% -34.3% -37.1% -50.8% -53.5% 56.4% 63.6% 30.2% 24.9% -33.8% -19.9% 10.9% 12.2% 19.2% 15.6% -8.1% 36.5% 36.45%
Gross Margin 26.4% 69.3% 63.2% 62.5% 53.3% 50.1% 72.2% 67.8% 82.5% 52.7% 15.5% 30.6% 29.8% 53.4% 78.7% 19.1% 62.5% 53.4% 49.4% 87.8% 87.77%
Operating Margin -1.4% -15.6% -66.7% -11.6% -63.1% -22.0% -29.0% -25.6% 58.2% -18.2% -53.5% -1.3% -18.0% 22.2% 39.6% -41.0% 7.5% 11.9% -51.1% 62.7% 62.65%
Net Margin -1.7% -34.8% -78.0% -14.2% -60.9% -25.1% -43.4% -32.7% 55.1% -17.9% -57.6% -1.2% -16.4% 18.0% 35.6% -35.8% 1.0% 13.2% -60.3% 54.3% 54.27%
EBITDA Margin -1.4% -12.5% -63.7% -8.7% -50.8% -18.7% -26.5% -20.9% 60.6% -9.2% -50.9% -1.1% -11.8% 24.9% 42.0% -33.4% 11.5% 15.6% -46.8% 63.9% 63.85%
FCF Margin -32.3% -28.5% -30.6% -17.6% -46.9% -59.6% -53.8% -55.5% -15.7% -13.6% -3.8% 7.3% -11.0% 15.7% 13.8% -2.6% -5.6% -18.9% -22.7% 19.2% 19.16%
OCF Margin -30.1% -25.9% -26.8% -14.6% -44.3% -57.8% -52.5% -53.9% -14.6% -11.8% -2.0% 9.8% -7.1% 18.1% 16.2% -1.0% -3.5% -16.2% -22.7% 19.8% 19.76%
ROE 3Y Avg snapshot only 20.41%
ROA 3Y Avg snapshot only 10.68%
ROIC 3Y Avg snapshot only 17.76%
ROIC Economic snapshot only 28.63%
Cash ROA snapshot only 18.33%
Cash ROIC snapshot only 36.04%
CROIC snapshot only 34.95%
NOPAT Margin snapshot only 20.62%
Pretax Margin snapshot only 25.22%
R&D / Revenue snapshot only 28.17%
SGA / Revenue snapshot only 15.88%
SBC / Revenue snapshot only -0.01%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -4.18 -2.95 -1.37 -1.99 -2.79 -2.88 -4.71 -7.65 18.69 13.10 15.62 13.44 -5.84 -8.62 51.97 50.19 19.17 33.26 -21.41 11.75 10.937
P/S Ratio 1.81 1.23 0.99 1.13 1.14 1.08 1.48 2.93 2.47 2.19 1.98 1.54 2.25 1.81 2.85 3.28 1.94 2.90 2.68 2.36 2.215
P/B Ratio -3.21 -2.24 -6.26 -8.05 -8.55 -8.53 -6.61 -11.34 -15.64 -13.07 3.87 2.74 2.56 2.47 3.53 4.54 2.78 4.15 2.93 3.74 2.494
P/FCF -5.59 -4.32 -3.22 -6.41 -2.42 -1.82 -2.74 -5.29 -15.75 -16.10 -52.64 21.06 -20.51 11.55 20.62 -125.56 -34.93 -15.34 -11.79 12.31 12.314
P/OCF 15.68 10.01 17.57 11.94 11.943
EV/EBITDA -10.49 -8.58 -1.72 -2.52 -3.60 -3.30 -7.57 -11.59 12.43 9.40 8.73 6.88 -5.79 -10.19 18.88 23.30 8.62 16.92 -44.18 7.95 7.948
EV/Revenue 2.35 1.75 0.84 1.00 1.01 0.97 1.71 3.21 2.63 2.36 1.73 1.26 1.81 1.44 2.30 2.79 1.47 2.43 2.56 2.28 2.276
EV/EBIT -9.46 -7.70 -1.63 -2.37 -3.32 -3.06 -6.88 -10.57 13.49 10.13 9.61 7.75 -5.24 -8.50 23.60 28.60 9.91 20.12 -29.87 8.54 8.543
EV/FCF -7.26 -6.16 -2.75 -5.68 -2.16 -1.62 -3.19 -5.79 -16.82 -17.41 -45.80 17.20 -16.48 9.20 16.65 -106.80 -26.42 -12.84 -11.26 11.88 11.879
Earnings Yield -23.9% -33.9% -72.9% -50.2% -35.8% -34.7% -21.2% -13.1% 5.3% 7.6% 6.4% 7.4% -17.1% -11.6% 1.9% 2.0% 5.2% 3.0% -4.7% 8.5% 8.51%
FCF Yield -17.9% -23.2% -31.1% -15.6% -41.3% -55.1% -36.4% -18.9% -6.3% -6.2% -1.9% 4.7% -4.9% 8.7% 4.9% -0.8% -2.9% -6.5% -8.5% 8.1% 8.12%
Price/Tangible Book snapshot only 3.737
EV/OCF snapshot only 11.521
EV/Gross Profit snapshot only 3.253
Acquirers Multiple snapshot only 8.785
Shareholder Yield snapshot only 0.00%
Graham Number snapshot only $1.55
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 0.64 0.64 1.86 1.86 1.86 1.86 1.38 1.38 1.38 1.38 1.54 1.54 1.54 1.54 2.34 2.34 2.34 2.34 2.51 2.51 2.514
Quick Ratio 0.49 0.49 1.32 1.32 1.32 1.32 0.87 0.87 0.87 0.87 1.12 1.12 1.12 1.12 1.52 1.52 1.52 1.52 1.54 1.54 1.544
Debt/Equity -2.38 -2.38 -5.55 -5.55 -5.55 -5.55 -3.15 -3.15 -3.15 -3.15 0.82 0.82 0.82 0.82 0.13 0.13 0.13 0.13 0.17 0.17 0.173
Net Debt/Equity -0.50 -0.50 -0.50 -0.50 -0.68 -0.68 -0.68 -0.68 -0.13 -0.13 -0.132
Debt/Assets 0.95 0.95 0.45 0.45 0.45 0.45 0.60 0.60 0.60 0.60 0.33 0.33 0.33 0.33 0.08 0.08 0.08 0.08 0.10 0.10 0.101
Debt/EBITDA -6.00 -6.39 -1.79 -1.96 -2.62 -2.40 -3.10 -2.94 2.34 2.09 2.14 2.53 -2.33 -4.28 0.85 0.77 0.52 0.62 -2.72 0.38 0.380
Net Debt/EBITDA -2.41 -2.57 0.29 0.32 0.43 0.40 -1.05 -0.99 0.79 0.71 -1.30 -1.54 1.42 2.61 -4.49 -4.09 -2.78 -3.30 2.08 -0.29 -0.291
Interest Coverage -1.34 -1.21 -2.33 -2.61 -2.57 -4.15 -4.57 -4.75 3.98 4.74 3.69 3.31 -6.61 -4.24 4.91 8.60 8.39 7.65 -3.34 13.22 13.224
Equity Multiplier -2.51 -2.51 -12.20 -12.20 -12.20 -12.20 -5.24 -5.24 -5.24 -5.24 2.52 2.52 2.52 2.52 1.70 1.70 1.70 1.70 1.71 1.71 1.707
Cash Ratio snapshot only 0.554
Debt Service Coverage snapshot only 14.213
Cash to Debt snapshot only 1.764
FCF to Debt snapshot only 1.759
Defensive Interval snapshot only 255.1 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.85 0.87 0.54 0.61 0.64 0.67 0.74 0.64 1.04 0.98 0.93 0.85 0.54 0.65 0.68 0.76 0.78 0.78 0.68 0.98 0.981
Inventory Turnover 1.42 1.50 1.05 1.14 1.09 1.31 1.13 0.96 1.08 0.95 1.28 1.26 1.44 1.63 1.21 1.48 1.31 1.30 1.15 0.98 0.977
Receivables Turnover 14.34 14.72 14.09 15.85 16.70 17.48 11.87 10.25 16.81 15.85 13.29 12.10 7.72 9.26 13.05 14.61 15.14 15.12 8.98 13.00 13.002
Payables Turnover 2.20 2.33 2.30 2.48 2.39 2.86 3.05 2.59 2.91 2.57 4.51 4.42 5.07 5.75 5.49 6.75 5.94 5.93 5.51 4.69 4.685
DSO 25 25 26 23 22 21 31 36 22 23 27 30 47 39 28 25 24 24 41 28 28.1 days
DIO 256 243 346 321 334 278 324 381 339 384 285 291 254 223 302 246 279 280 318 374 373.7 days
DPO 166 157 159 147 153 127 120 141 125 142 81 83 72 63 66 54 61 62 66 78 77.9 days
Cash Conversion Cycle 116 111 214 197 203 172 235 276 235 265 231 238 229 199 264 217 242 243 292 324 323.9 days
Fixed Asset Turnover snapshot only 6.072
Operating Cycle snapshot only 401.8 days
Cash Velocity snapshot only 5.203
Capital Intensity snapshot only 1.078
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue -25.7% -19.4% -39.0% -18.0% -5.4% -3.5% 24.2% -4.6% 48.5% 33.8% 37.5% 45.0% -43.6% -28.2% -18.5% 0.2% 62.8% 35.4% -1.2% 27.8% 27.80%
Net Income -2.6% -2.1% -3.2% -78.5% 10.9% 13.0% 45.9% 35.3% 1.5% 1.6% 1.6% 1.4% -2.7% -1.9% -64.7% -42.9% 1.4% 1.6% -3.3% 2.9% 2.92%
EPS -1.6% -1.2% -2.1% -55.5% 14.5% 19.9% 52.0% 48.4% 1.3% 1.4% 1.4% 1.3% -2.9% -1.9% -68.3% -45.6% 1.4% 1.6% -3.3% 2.6% 2.62%
FCF 31.2% 38.0% 56.1% 74.6% -37.3% -1.0% -1.2% -2.0% 50.4% 69.5% 90.4% 1.2% 60.4% 1.8% 4.0% -1.4% 17.6% -2.6% -2.6% 10.4% 10.37%
EBITDA -3.1% -3.5% -5.2% -3.4% -19.1% -38.4% 42.5% 33.4% 2.1% 2.1% 2.2% 2.0% -1.8% -1.4% -49.6% -34.5% 1.9% 2.4% -1.5% 2.1% 2.05%
Op. Income -5.1% -6.8% -8.6% -2.3% -18.8% -36.2% 36.4% 27.0% 1.8% 1.8% 1.8% 1.6% -2.2% -1.7% -62.6% -42.6% 1.6% 1.7% -2.4% 3.3% 3.28%
OCF Growth snapshot only 27.38%
Asset Growth snapshot only 12.16%
Equity Growth snapshot only 11.62%
Debt Growth snapshot only 50.58%
Shares Change snapshot only 8.40%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 35.3% 26.8% -7.7% -7.6% -9.9% -9.4% -4.5% -14.5% 1.4% 1.3% 1.4% 4.3% -7.5% -2.5% 11.7% 11.5% 10.9% 9.1% 3.5% 22.9% 22.91%
Revenue 5Y 33.0% 30.5% 23.2% 20.3% 19.9% 14.5% 28.3% 21.3% 6.1% 1.8% -9.3% -6.5% -0.5% -1.9% -0.8% 0.2% -3.5% 7.8% 7.76%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y 40.9% 58.3% 42.8%
EBITDA 5Y 36.4% 15.6% 17.1%
Gross Profit 3Y 1.0% 37.6% -15.6% -16.2% -18.8% -20.3% -13.8% -23.0% -2.9% -2.0% -6.5% -2.7% -28.1% -21.1% 9.7% 5.4% 7.8% 9.3% -2.8% 29.7% 29.69%
Gross Profit 5Y 94.0% 77.5% 67.1% 53.2% 47.5% 38.3% 66.4% 29.8% 3.0% -3.0% -25.4% -21.1% -7.9% -11.0% -7.7% -6.6% -13.1% 5.8% 5.78%
Op. Income 3Y 58.3% 87.2% 56.9%
Op. Income 5Y 21.5% 25.2%
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y -2.0% -2.0% 6.4% 6.4% 6.4% 6.4% 7.1% 7.1% 7.1% 7.1% 7.5% 7.5% 7.5% 7.5% -0.1% -0.1% -0.1% -0.1% 13.9% 13.9% 13.86%
Assets 5Y -6.9% -6.9% -2.2% -2.2% -2.2% -2.2% -5.0% -5.0% -5.0% -5.0% 6.7% 6.7% 6.7% 6.7% 10.1% 10.1% 10.1% 10.1% 3.9% 3.9% 3.92%
Equity 3Y
Book Value 3Y
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.70 0.71 0.44 0.36 0.26 0.27 0.26 0.11 0.52 0.56 0.06 0.01 0.17 0.22 0.08 0.01 0.05 0.01 0.13 0.53 0.527
Earnings Stability 0.46 0.49 0.20 0.46 0.52 0.49 0.33 0.07 0.46 0.43 0.15 0.10 0.02 0.06 0.42 0.37 0.20 0.27 0.23 0.76 0.759
Margin Stability 0.52 0.80 0.49 0.53 0.54 0.56 0.59 0.62 0.60 0.82 0.84 0.85 0.69 0.71 0.84 0.82 0.69 0.71 0.79 0.84 0.840
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.50 0.50 1.00 0.50 0.00 0.00 0.00 1.00 0.50 0.50 0.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.50 0.50 0.96 0.95 0.82 0.86 0.20 0.20 0.20 0.20 0.20 0.20 0.50 0.50 0.20 0.20 0.20 0.50 0.500
Earnings Smoothness 0.04 0.45 0.00 0.000
ROE Trend -0.29 0.17 0.171
Gross Margin Trend -0.15 -0.15 -0.24 -0.20 -0.13 -0.18 -0.11 -0.08 0.07 0.12 0.07 0.03 -0.35 -0.30 -0.07 -0.11 0.05 0.03 -0.11 0.14 0.138
FCF Margin Trend -0.12 0.06 0.09 0.26 -0.13 -0.27 -0.17 -0.18 0.24 0.30 0.38 0.44 0.20 0.52 0.43 0.21 0.08 -0.20 -0.28 0.17 0.168
Sustainable Growth Rate 72.5% 59.7% 7.6% 10.2% 16.3% 14.1% 33.5% 33.53%
Internal Growth Rate 15.9% 19.6% 13.5% 10.8% 3.9% 5.2% 8.6% 7.3% 24.5% 24.51%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.70 0.62 0.37 0.26 1.09 1.54 1.67 1.41 -1.11 -0.71 -0.16 0.86 0.18 -0.86 2.96 -0.15 -0.35 -1.86 1.82 0.98 0.984
FCF/OCF 1.07 1.10 1.14 1.21 1.06 1.03 1.03 1.03 1.07 1.15 1.87 0.74 1.54 0.87 0.85 2.73 1.57 1.17 1.00 0.97 0.970
FCF/Net Income snapshot only 0.955
OCF/EBITDA snapshot only 0.690
CapEx/Revenue 2.2% 2.6% 3.8% 3.0% 2.5% 1.8% 1.3% 1.6% 1.1% 1.7% 1.8% 2.5% 3.9% 2.4% 2.4% 1.7% 2.0% 2.7% 0.0% 0.6% 0.60%
CapEx/Depreciation snapshot only 0.299
Accruals Ratio -0.11 -0.14 -0.24 -0.26 0.02 0.14 0.16 0.10 0.29 0.28 0.14 0.01 -0.17 -0.26 -0.07 0.06 0.11 0.20 0.07 0.00 0.003
Sloan Accruals snapshot only 0.054
Cash Flow Adequacy snapshot only 33.165
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -63.5% -84.3% -1.2% 0.0% -5.1% -8.1% -11.7% -18.6% -17.8% -20.2% -18.4% -10.6% 0.0% 0.0% -2.4% -3.3% -8.7% -5.8% -4.9% -2.4% -2.36%
Total Shareholder Return -63.5% -84.3% -1.2% 0.0% -5.1% -8.1% -11.7% -18.6% -17.8% -20.2% -18.4% -10.6% 0.0% 0.0% -2.4% -3.3% -8.7% -5.8% -4.9% -2.4% -2.36%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.04 1.05 0.90 0.90 0.97 1.01 0.97 1.00 0.71 0.76 0.78 0.83 1.18 0.80 0.796
Interest Burden (EBT/EBIT) 1.74 1.83 1.39 1.34 1.33 1.19 1.21 1.21 0.75 0.79 0.73 0.70 1.15 1.24 0.80 0.88 0.88 0.87 1.24 0.95 0.947
EBIT Margin -0.25 -0.23 -0.52 -0.42 -0.31 -0.32 -0.25 -0.30 0.20 0.23 0.18 0.16 -0.35 -0.17 0.10 0.10 0.15 0.12 -0.09 0.27 0.266
Asset Turnover 0.85 0.87 0.54 0.61 0.64 0.67 0.74 0.64 1.04 0.98 0.93 0.85 0.54 0.65 0.68 0.76 0.78 0.78 0.68 0.98 0.981
Equity Multiplier -1.16 -1.16 -4.28 -4.28 -4.28 -4.28 -7.76 -7.76 -7.76 -7.76 6.12 6.12 6.12 6.12 2.06 2.06 2.06 2.06 1.70 1.70 1.703
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-0.46 $-0.45 $-0.61 $-0.53 $-0.39 $-0.36 $-0.29 $-0.27 $0.11 $0.13 $0.11 $0.09 $-0.20 $-0.12 $0.04 $0.05 $0.08 $0.07 $-0.08 $0.18 $0.18
Book Value/Share $-0.60 $-0.59 $-0.13 $-0.13 $-0.13 $-0.12 $-0.21 $-0.19 $-0.13 $-0.13 $0.46 $0.46 $0.46 $0.41 $0.53 $0.56 $0.53 $0.53 $0.61 $0.58 $0.84
Tangible Book/Share $-0.60 $-0.59 $-0.13 $-0.13 $-0.13 $-0.12 $-0.21 $-0.19 $-0.13 $-0.13 $0.46 $0.46 $0.46 $0.41 $0.53 $0.56 $0.53 $0.53 $0.61 $0.58 $0.58
Revenue/Share $1.06 $1.08 $0.84 $0.94 $0.96 $0.96 $0.93 $0.72 $0.81 $0.76 $0.90 $0.82 $0.52 $0.56 $0.66 $0.78 $0.76 $0.77 $0.67 $0.92 $0.96
FCF/Share $-0.34 $-0.31 $-0.26 $-0.17 $-0.45 $-0.57 $-0.50 $-0.40 $-0.13 $-0.10 $-0.03 $0.06 $-0.06 $0.09 $0.09 $-0.02 $-0.04 $-0.14 $-0.15 $0.18 $0.18
OCF/Share $-0.32 $-0.28 $-0.23 $-0.14 $-0.43 $-0.56 $-0.49 $-0.39 $-0.12 $-0.09 $-0.02 $0.08 $-0.04 $0.10 $0.11 $-0.01 $-0.03 $-0.12 $-0.15 $0.18 $0.19
Cash/Share $0.85 $0.85 $0.86 $0.85 $0.82 $0.79 $0.43 $0.39 $0.27 $0.26 $0.61 $0.61 $0.61 $0.55 $0.43 $0.45 $0.43 $0.43 $0.19 $0.18 $0.65
EBITDA/Share $-0.24 $-0.22 $-0.41 $-0.37 $-0.27 $-0.28 $-0.21 $-0.20 $0.17 $0.19 $0.18 $0.15 $-0.16 $-0.08 $0.08 $0.09 $0.13 $0.11 $-0.04 $0.26 $0.26
Debt/Share $1.42 $1.41 $0.73 $0.73 $0.71 $0.68 $0.65 $0.58 $0.40 $0.40 $0.38 $0.38 $0.38 $0.34 $0.07 $0.07 $0.07 $0.07 $0.11 $0.10 $0.10
Net Debt/Share $0.57 $0.57 $-0.12 $-0.12 $-0.12 $-0.11 $0.22 $0.20 $0.14 $0.13 $-0.23 $-0.23 $-0.23 $-0.21 $-0.36 $-0.38 $-0.36 $-0.36 $-0.08 $-0.08 $-0.08
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score -1.048
Altman Z-Prime snapshot only -4.835
Piotroski F-Score 2 2 3 4 4 3 3 3 4 4 5 6 4 6 5 3 5 6 3 7 7
Beneish M-Score -2.69 -3.49 -0.98 -3.00 -1.96 -1.00 -1.58 -1.51 0.90 -0.78 0.57 -0.34 -0.67 -2.56 -3.17 -1.00 -2.52 -1.96 2.09 -0.80 -0.798
Ohlson O-Score snapshot only -8.467
ROIC (Greenblatt) snapshot only 38.59%
Net-Net WC snapshot only $0.39
EVA snapshot only $11563515.73
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BBB+
Credit Score 12.69 12.72 20.00 20.00 20.00 20.00 19.96 20.00 20.00 20.00 38.73 42.95 25.01 32.51 55.58 54.02 53.61 53.09 30.80 63.63 63.631
Credit Grade snapshot only 8
Credit Trend snapshot only 9.608
Implied Spread (bps) snapshot only 225.000
Industry Credit Rank snapshot only 61
Sector Credit Rank snapshot only 57

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms